Product Description
The CSI Cup (CLIA Screen In-Vitro) is the most reliable and cost effective 6 Panel Drug Screen Cup in the market from www.DrugTestingForLess.com All the administrator needs to do is simply peel the label and view the testing results!
Excellent Design
- Click Seal Cap for leak-proof transportation
- Simple procedure with no additional steps required to activate test
- Leak resistant screw cap lid with O-Ring
- Test format from 5-14 drugs per cup plus up to 6 adulterants
- Customized configurations available
Reliable Results
- Easy-to-read result displayed in strong color code
- Long-lasting results stable for up to 1 hour
- 99% accuracy compared to GC/MS data in the clinical comparison studies
- 24 Month Shelf Life from Date of Manufacture
- Set to SAMHSA Cutoff Levels
- CLIA Waived [FDA 510(k) #K153597]
- OTC Approved (Over the Counter)
- Health Canada Approved
Download & Print Reference Documents
CSI Cup Multi-Drug CLIA Waived Package Insert
CSI Cup Multi-Drug CLIA Waived Procedure Card
6-Panel Configurations (Choose Below)
Order Number | Panel Configurations (Choose Above) | Adulterants |
CSI-CUP-265 | AMP, BZO, COC, MET, MOP, THC | NONE |
CSI-CUP-264 | AMP, BZO, COC, MET, OPI, THC | NONE |
FDA 510(k) & SAMSHA Approved CLIA Waived Drug Panels | |||||
Drug Name | Abbreviation | Cutoff Level | Minimum Detection Time in Urine* | Maximum Detection Time in Urine* | Calibrator |
Amphetamines | AMP | 1000 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
Amphetamines | AMP | 500 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
Barbiturates | BAR | 300 ng/ml | 2-4 hours | 1-3 weeks | Secobarbital |
Benzodiazepines | BZO / BZD | 300 ng/ml | 2-7 hours | 1-4 days | Benzoylecgonine |
Buprenorphine | BUP | 10 ng/ml | 2-3 hours | 1 day | Buprenorphine |
Cocaine | COC | 300 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
Cocaine | COC | 150 ng/mL | 1-4 Hours | 2-4 Days | Benzoylecgonine |
Ecstasy | MDMA | 500 ng/ml | 1-3 days | 1-2 days | D,L- Methylenedioxy-methamphetamine |
EDDP | EDDP | 300 ng/ml | 1-4 hours | 2-4 days | 2-Ethylidene-1,5-dimethyl-3,3-dipheylpyrrolidine |
Marijuana | THC | 50 ng/ml | 2 hours | up to 40 days | 11-nor-∆9-THC-9 COOH |
Methadone | MTD / MAD | 300 ng/ml | 3-8 hours | 1-3 days | Methadone |
Methamphetamine | mAMP / MET | 1000 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
Methamphetamine | mAMP / MET | 500 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
Morphine | MOP / OPI-300 | 300 ng/ml | 2 hours | 2-3 days | Morphine |
Opiates | OPI | 2000 ng/ml | 2 hours | 2-3 days | Morphine |
Oxycodone | OXY | 100 ng/ml | 1-3 hours | 1-2 days | Oxycodone |
Phencyclidine | PCP | 25 ng/ml | 4-6 hours | 7-14 days | Phencyclidine |
Propoxyphene | PPX | 300 ng/ml | 1-2 days | N/A | Propoxyphene |
Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours | 2-7 days | Nortriptyline |
* Detection times are not guaranteed. Reference configuration above for included drug panels. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. |